Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: REJUVENATE BIO INC.
Awarding agency: Department of Defense / U.S. Special Operations Command
Funding agency: Department of Defense / U.S. Special Operations Command
Period of performance: 2022-06-07 to 2024-06-07
Current total value of award: $2992731
Description: SBIR PH II TOPIC 182-002 NEUROENHANCEMENT